255 related articles for article (PubMed ID: 27206902)
1. Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.
Cassani E; Cilia R; Laguna J; Barichella M; Contin M; Cereda E; Isaias IU; Sparvoli F; Akpalu A; Budu KO; Scarpa MT; Pezzoli G
J Neurol Sci; 2016 Jun; 365():175-80. PubMed ID: 27206902
[TBL] [Abstract][Full Text] [Related]
2.
Cilia R; Laguna J; Cassani E; Cereda E; Pozzi NG; Isaias IU; Contin M; Barichella M; Pezzoli G
Neurology; 2017 Aug; 89(5):432-438. PubMed ID: 28679598
[TBL] [Abstract][Full Text] [Related]
3. Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.
Cilia R; Laguna J; Cassani E; Cereda E; Raspini B; Barichella M; Pezzoli G
Parkinsonism Relat Disord; 2018 Apr; 49():60-66. PubMed ID: 29352722
[TBL] [Abstract][Full Text] [Related]
4. Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations.
Contin M; Lopane G; Passini A; Poli F; Iannello C; Guarino M
Clin Neuropharmacol; 2015; 38(5):201-3. PubMed ID: 26366963
[TBL] [Abstract][Full Text] [Related]
5. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
Katzenschlager R; Evans A; Manson A; Patsalos PN; Ratnaraj N; Watt H; Timmermann L; Van der Giessen R; Lees AJ
J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1672-7. PubMed ID: 15548480
[TBL] [Abstract][Full Text] [Related]
6. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.
Lieu CA; Kunselman AR; Manyam BV; Venkiteswaran K; Subramanian T
Parkinsonism Relat Disord; 2010 Aug; 16(7):458-65. PubMed ID: 20570206
[TBL] [Abstract][Full Text] [Related]
7. Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report.
Radder DLM; Tiel Groenestege AT; Boers I; Muilwijk EW; Bloem BR
J Parkinsons Dis; 2019; 9(2):437-439. PubMed ID: 30856121
[TBL] [Abstract][Full Text] [Related]
8. Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson's disease--In relation to the effects of Mucuna pruriens.
Nagashima Y; Kondo T; Sakata M; Koh J; Ito H
J Neurol Sci; 2016 Feb; 361():229-34. PubMed ID: 26810548
[TBL] [Abstract][Full Text] [Related]
9. Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?
Fothergill-Misbah N; Maroo H; Cham M; Pezzoli G; Walker R; Cilia R
Parkinsonism Relat Disord; 2020 Apr; 73():3-7. PubMed ID: 32179240
[TBL] [Abstract][Full Text] [Related]
10. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.
Kasture S; Pontis S; Pinna A; Schintu N; Spina L; Longoni R; Simola N; Ballero M; Morelli M
Neurotox Res; 2009 Feb; 15(2):111-22. PubMed ID: 19384573
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection.
Soumyanath A; Denne T; Hiller A; Ramachandran S; Shinto L
J Altern Complement Med; 2018 Feb; 24(2):182-186. PubMed ID: 28922612
[TBL] [Abstract][Full Text] [Related]
13. Japanese Mucuna pruriens (Hasshou beans) Showed Fast-acting and Long-lasting Effects in Parkinson's Disease.
Sakata M; Miyamoto K; Koh J; Nagashima Y; Kondo T; Ito H
Intern Med; 2024 Mar; ():. PubMed ID: 38462520
[TBL] [Abstract][Full Text] [Related]
14. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-Reduced
Johnson SL; Park HY; DaSilva NA; Vattem DA; Ma H; Seeram NP
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30131460
[No Abstract] [Full Text] [Related]
16. Neuroprotective effects of the antiparkinson drug Mucuna pruriens.
Manyam BV; Dhanasekaran M; Hare TA
Phytother Res; 2004 Sep; 18(9):706-12. PubMed ID: 15478206
[TBL] [Abstract][Full Text] [Related]
17. Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson's disease.
Nagayama H; Ueda M; Kumagai T; Tsukamoto K; Nishiyama Y; Nishimura S; Hamamoto M; Katayama Y
Parkinsonism Relat Disord; 2011 Mar; 17(3):150-2. PubMed ID: 21172738
[TBL] [Abstract][Full Text] [Related]
18. [Survey on the Current Advertising and Sales of Mucuna pruriens in Consumer-to-consumer Internet Trading in Japan].
Sato K; Hida A; Niimi Y; Iwata A; Iwatsubo T
Yakugaku Zasshi; 2023 Dec; 143(12):1057-1067. PubMed ID: 37839871
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Physicochemical Stability of the L-DOPA Extract of
Vilairat C; Kobtrakul K; Vimolmangkang S
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838562
[TBL] [Abstract][Full Text] [Related]
20. Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson's Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study.
Onofrj M; Thomas A; Vingerhoets F; Martin W; Giménez-Roldán S; Azulay JP; Bernhard G; Schmidt W; Markabi S
J Neural Transm (Vienna); 2004 Aug; 111(8):1053-63. PubMed ID: 15254793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]